Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ACTRN12626000702314) titled 'Using patient-specific clinical characteristics and genetic testing to predict the best weight loss medication for adults with obesity' on June 12.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Open (masking not used)
Assignment: Parallel
Type of endpoint: Safety/efficacy
Primary Sponsor: MetroSouth Health, Queensland Health
Condition:
Obesity
Overweight with metabolic comorbidities
Obesity
Overweight with metabolic comorbidities
Metabolic and Endocrine - Metabolic disorders
Diet and Nutrition - Obesity
Intervention:
Arm 1:
- Phentermine +...